Zogenix, Inc. Announces Availability of New Resources for Migraine Sufferers at www.SUMAVELDosePro.com to Support National Pain Awareness Month

SAN DIEGO, Sept. 27, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, announced today the availability of new migraine patient resources accessible at www.SUMAVELDosePro.com in support of National Pain Awareness Month. One in every four households in the U.S. has a migraine sufferer, which impacts productivity in the workplace, in school and in managing household work. The new resources offer people affected by migraines, as well as caregivers, family and friends, an opportunity to learn more about the condition, view video testimonials from people who suffer from migraines and physicians who specialize in the treatment of headaches, and educate themselves on the U.S. Headache Consortium Migraine Treatment Guidelines provided by the American Headache Society and the American Academy of Neurology.